3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Myelodysplastic Syndromes
1
Metabolism, Inborn Errors
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Immunologic Deficiency Syndromes
1
Hemoglobinopathies
1
Graft vs Host Disease
1
Congenital Bone Marrow Failure Syndromes
1
Carcinoma in Situ
1
Bone Marrow Failure Disorders
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Cyclophosphamide
17
fludarabine phosphate
12
pembrolizumab
11
Brentuximab Vedotin
11
Nivolumab
10
Mycophenolic Acid
10
fludarabine
9
Doxorubicin
9
Dacarbazine
9
Whole-Body Irradiation
8
Vinblastine
7
Magnetic Resonance Spectroscopy
7
Filgrastim
7
Etoposide
7
Cyclosporine
7
Specimen Handling
6
Sirolimus
5
Radiotherapy
5
Peripheral Blood Stem Cell Transplantation
5
Melphalan
5
Granulocyte Colony-Stimulating Factor
5
Busulfan
5
Tacrolimus
4
Gemcitabine
4
pegfilgrastim
3
Vinorelbine
3
Radiation
3
Cyclosporins
3
Carmustine
3
thymoglobulin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
Clinical Trials, Phase I as Topic
×
90 days
×
Clear all
No trials found.